SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenus BOT+BAL combination drew attention after reported long-term survival data in recurrent ovarian cancer, with traders welcoming the durability signal and arguing it could support broader use. Others cautioned that the findings come from a small Phase 1b cohort and the treatment remains investigational, while some attributed the stocks pullback to profit-taking or speculation about undisclosed news.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

Bankrs expanding AI-agent trading infrastructure and ecosystem integrations dominate discussion, with traders citing onchain activity, token launches, and fee-linked value accrual as the projects potential fundamentals. Sentiment is largely bullish on long-term utility, though some holders question whether that activity will translate into price gains amid volatility and pullbacks.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

Midnights mainnet rollout and ecosystem developmentsincluding validator participation and new exchange accessare drawing attention, with traders hopeful they can boost adoption. Others remain cautious, citing ongoing airdrop-related selling and weak follow-through.

The mission of the Worldcoin project is to build the world’s largest identity and financial network as a public utility, giving ownership to everyone. A key component of the Worldcoin project is the development of the foundational infrastructure that will be important for a world where AI plays an increasingly large role.  The Worldcoin system revolves around World ID, a privacy-preserving global identity network. World ID enables users to verify their humanness online while maintaining their privacy through zero-knowledge proofs.  Using World ID, individuals will be able to prove that they are a real, unique human to any platform that integrates with the protocol, including to web3 systems, social networking sites, and governmental programs. This will enable fair airdrops or token/NFT sales, provide protection against bots/sybil attacks on social media, and enable the fairer distribution of limited governmental resources. Furthermore, World ID can also enable global democratic processes and novel forms of governance (e.g., via quadratic voting), and it may eventually show a path to AI-funded UBI. The Worldcoin token (WLD), alongside World ID, will let users participate in governing the Worldcoin protocol.   To engage with the Worldcoin protocol, individuals must first download a first wallet app that supports the creation of a World ID. Users visit a physical imaging device called the Orb to get their World ID Orb-verified. Orbs are operated by a network of independent local businesses called Orb Operators. The Orb uses multispectral sensors to verify humanness and uniqueness to issue an Orb-verified World ID, with all images being promptly deleted on-device per default (absent explicit consent to Data Custody). All Orb-verified World IDs holders are entitled to claim recurring grants of free WLD tokens, subject to certain availability restrictions. The WLD token is designed as a utility token with governance properties.

Worldcoin

Worldcoins rally and heavy trading volume are drawing attention, with traders pointing to Grayscales ETF filing, Eightco/ORBSs reported large WLD holdings, and demand for proof-of-humanity tools as AI agents proliferate. Bullish enthusiasm is tempered by concerns about volatility, token supply, and speculation around prominent traders involvement.

the cat on Base  community-run home for $BASECAT

Basecat

Trading around BASECATs Coinbase launch has been highly volatile, with discussion focused on a steep pullback and persistent selling pressure. Traders are split between calling it a pump-and-dump and buying dips on hopes of a reversal, with some pointing to rising whale holdings as possible accumulation.

PolySwarm

A sharp pickup in trading volume and an unexplained price move have traders watching NCT, with some pointing to heavy South Korean trading and past rallies as a possible driver. Others see no confirmed catalyst and caution that the activity could be another speculative pump-and-dump.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ais quarterly results are driving discussion: an earnings beat and positive cash flow were offset by sharply lower revenue and a weaker-than-expected near-term outlook. Traders are split between concerns about the companys prolonged turnaround and hopes that improving bookings, cost cuts, and high short interest could support a rebound.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

TAO is drawing attention amid a pullback after its recent rally, with traders attributing selling pressure partly to renewed Iran-related geopolitical concerns and broader crypto-market weakness. Some see the failed bounce and ongoing correction as reasons for caution, while long-term bulls point to subnet revenue and ecosystem growth as reasons to keep accumulating.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinzs prolonged share-price decline has sparked a debate over whether its high dividend and low valuation offer value or whether weak growth and years of underperformance outweigh the income appeal. Some investors see a turnaround under new management, while frustrated holders blame short-selling and question when the business will show sustained improvement.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

A reported federal loan package for upgrades at Vistras nuclear plants is driving attention, with traders linking the planned capacity expansion to rising AI and data-center electricity demand. Many view the potential financing as bullish, while others question why the shares remain choppy and emphasize that the package is still reported rather than finalized.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nateras strong quarterly results and upbeat outlook are being discussed alongside a run to fresh 52-week highs, with traders highlighting growth in its diagnostics business. Bulls see continued momentum, while skeptics argue the valuation is stretched and the rally may be vulnerable to a pullback.

$1000 Invested In Natera 5 Years Ago Would Be Worth This Much Today

Natera (NASDAQ:NTRA) has outperformed the market over the past 5 years by 17.64% on an annualized basis producing an average annual return of 29.65%. Currently, Natera has a market capitalization of $59.35 billion.read more...

Natera, UnitedHealth Group And A Tech Stock On CNBC's 'Final Trades'

CNBC's Final Trades: Rob Sechan picks Hewlett Packard, Kevin Simpson favors Natera, and Stephen Weiss recommends UnitedHealth.read more...

Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx

NTRA wins Japan PMDA approval for Signatera in muscle-invasive bladder cancer, supporting treatment decisions and a planned 2027 commercial launch.

NTRA Stock Hits All-Time High, OMER Stock Scales 5-Year Peak – What’s Driving Investors’ Enthusiasm Today?

Equity

Natera’s Signatera test secured a key regulatory approval, while Cantor raised its sales expectations for Omeros’ lead drug, Yartemlea.

Natera Announces Japan's PMDA Authorization For Signatera In Muscle-Invasive Bladder Cancer

(RTTNews) - Natera, Inc. (NTRA) announced that its Signatera test has received regulatory approval from Japan's Pharmaceuticals and Medical Devices Agency as a companion diagnostic in
muscle-invasive bladder cancer. The approval supports the use of the Signatera test to guide ad...

Uber, Micron, Datadog And A Health Care Stock: CNBC's 'Final Trades'

CNBC's Final Trades featured Uber, Micron, Natera and Datadog, with analysts citing bullish views and all four stocks posting gains.read more...

Signatera Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that its Signatera test has received regulatory approval from Japans Pharmaceuticals and Medical Devices Agency (PMDA) as a companion diagnostic (CDx) in muscle-invasive bladder cancer (MIBC). This...

Natera CEO Steven Chapman Sells 1,698 Shares for $545,000

Key PointsThe disposal represented 2% of the total equity stake held by the executive prior to the transaction...

Largest MRD Study in Lung Cancer Highlights Strong Prognostic Value for SignateraTM

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced new data that was recently presented at the IASLC 2026 World Conference on Lung Cancer (WCLC) in Seoul, South Korea. Natera and its collaborators presented four abstracts, including two oral...

Jim Cramer Calls Natera (NTRA) "a Promising Story"

Jim Cramer Calls Natera (NTRA) "a Promising Story...

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

Natera Inc

Neutral Sentiment

Up more than 5%

Flat to up 5%

Flat to down 5%

Down more than 5%

What&#39;s your expected total return for the S&amp;P 500 ($SPY) in Q4? 

Drop your reasoning in the comments.

Stocktwits

What's your expected total return for the S&P 500 (

) in Q4? 

Drop your reasoning in the comments.

Current Price	$410.35
Prev Close	$408.47
Open	$409.40
Dividend Yield	0.00%
50-Day Moving Average	$331.07
Beta	1.31
Avg. Volume	1.54M
PE Ratio	-299.83

52-Week High	$427.47
52-Week Low	$167.22
Market Capitalization	$59.15B
EPS (Annual)	-$1.52
Price to Book	32.35
Revenue Per Employee	$375,588.44

Feed

News

Sentiment

Earnings

Fundamentals

Info

NTRA Fundamentals